Informação sobre produto
Tetraglyme-d6 is a medicinal compound that has been developed as an analog of a protein kinase inhibitor. This compound has shown potent anticancer activity in human cancer cells and has been found to induce apoptosis, or programmed cell death, in tumor cells. Tetraglyme-d6 inhibits the activity of kinases, which are enzymes that play a critical role in the regulation of cellular processes such as growth and division. This inhibition leads to the suppression of cancer cell growth and proliferation. The compound has been tested extensively in Chinese hamster ovary cells and its efficacy as an anticancer agent has been demonstrated in vivo. Furthermore, it has also been detected in urine samples from patients with cancer who have received treatment with this inhibitor. Tetraglyme-d6 is a promising candidate for further development as a potent anticancer drug.
Propriedades químicas
Consulta técnica sobre: 3D-RYB62815 Tetraglyme-d6
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.
